Skip to content

CVKD

Cadrenal Therapeutics, Inc. Common Stock

NASDAQ · USHealthcareBiotechnology
$2.15-0.23%

Price as of Jul 20, 2026

CVKD earnings

Cadrenal Therapeutics, Inc. Common Stock earnings

Reported EPS and revenue history, upcoming estimates and available earnings-call summaries.

Next earnings
Aug 10, 2026in NaN days
EPS est $-1.55 · Revenue est
Track record
Beat EPS in 2 of 8 quarters
Avg surprise -19.3% (last 4 quarters)
Earnings history
Report dateEPS estEPS actualSurpriseRevenueRev. surprise
May 7, 2026$-1.51$-1.04+31.1%
Mar 31, 2026$-1.17$-1.41-20.5%
May 8, 2025$-1.64$-2.09-27.4%
Mar 13, 2025$-1.71$-2.74-60.2%$2134
Nov 7, 2024$-1.83$-2.18-19.1%
May 9, 2024$-1.05$-1.50-42.9%
Mar 11, 2024$-1.35$-0.75+44.4%$2768
Nov 9, 2023$-1.05$-1.05+0.0%
Aug 10, 2023$-1.35
Jun 30, 2022$-0.04
Mar 31, 2022$-0.02

Earnings history is derived from company filings and calendar data. Call summaries are grouped by reporting period. Latest covered event: 2026-08-10.